Fasting and postprandial phenylalanine and leucine kinetics in liver cirrhosis.
To investigate body protein turnover and the pathogenesis of increased concentration of plasma phenylalanine in liver cirrhosis, we have studied phenylalanine and leucine kinetics in cirrhotic (diabetic and nondiabetic) patients, and in normal subjects, both in the postabsorptive state and during a mixed meal, using combined intravenous and oral isotope infusions. Postabsorptive phenylalanine concentration and whole body rate of appearance (Ra) were approximately 40% greater (P < 0.05) in patients than in controls. Leucine concentrations were comparable, but intracellular leucine Ra was also increased (P < 0.05), suggesting increased whole body protein breakdown. Postprandial phenylalanine Ra was also greater (P < 0.05) in the patients. This difference was due to a diminished fractional splanchnic uptake of the dietary phenylalanine (approximately 40% lower in the cirrhotics vs. controls, P < or = 0.05). Postprandial leucine Ra was also increased in the patients, but splanchnic uptake of dietary leucine was normal. Thus both increased body protein breakdown and decreased splanchnic extraction of dietary phenylalanine can account for the increased phenylalanine concentrations in liver cirrhosis.
Tessari
P
P
Department of Metabolic Diseases, University of Padua, Italy.
Inchiostro
S
S
Barazzoni
R
R
Zanetti
M
M
Orlando
R
R
Biolo
G
G
Sergi
G
G
Pino
A
A
Tiengo
A
A
D000328:Adult; D000368:Aged; D004435:Eating; D005215:Fasting; D005260:Female; D006728:Hormones / Q000097:blood; D006801:Humans; D007700:Kinetics; D007930:Leucine / Q000493:pharmacokinetics*; D008103:Liver Cirrhosis / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D009994:Osmolar Concentration; D010649:Phenylalanine / Q000493:pharmacokinetics*; D012016:Reference Values
D006728:Hormones; D010649:Phenylalanine; D007930:Leucine